[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  Psychedelic News Alerts [@psil_ai](/creator/twitter/psil_ai) on x XX followers Created: 2025-07-18 19:01:19 UTC "Phase X study EMBRACE, part of PARADIGM program, approved by UK MHRA for CYB003, receives Breakthrough Therapy Designation from FDA for MDD." #clinicaltrials #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF XXX engagements  **Related Topics** [$rvvtf](/topic/$rvvtf) [$numif](/topic/$numif) [$mnmd](/topic/$mnmd) [$atai](/topic/$atai) [$cmps](/topic/$cmps) [$cybn](/topic/$cybn) [breakthrough](/topic/breakthrough) [atai life](/topic/atai-life) [Post Link](https://x.com/psil_ai/status/1946284161678934444)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Psychedelic News Alerts @psil_ai on x XX followers
Created: 2025-07-18 19:01:19 UTC
"Phase X study EMBRACE, part of PARADIGM program, approved by UK MHRA for CYB003, receives Breakthrough Therapy Designation from FDA for MDD." #clinicaltrials #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF
XXX engagements
Related Topics $rvvtf $numif $mnmd $atai $cmps $cybn breakthrough atai life
/post/tweet::1946284161678934444